Drug detox for Jupiter — substance-specific protocols, not one-size-fits-all.

For Jupiter families, RECO Island's Delray Beach campus is 32 miles south on I-95 — about 45 minutes outside of rush hour. Close enough for weekly family sessions from Abacoa or Tequesta, far enough for genuine separation from local using environments. Small-census, physician-led detox with substance-specific protocols — COWS-guided buprenorphine induction for opioid use disorder, slow tapering for benzodiazepine dependence, supportive management for stimulant withdrawal, deliberate sequencing for polysubstance presentations. Direct in-house transition to residential and MAT continuation — no waitlists, no third-party handoffs to unfamiliar clinicians.

Jupiter to Delray Beach is 32 miles down I-95 — about 45 minutes outside of rush hour. For families in Abacoa, Jupiter Inlet Colony, Tequesta, Admirals Cove, or Jonathan’s Landing, that distance is close enough for weekly family sessions and far enough that the Delray campus provides genuine separation from local suppliers, using environments, and the sensory cues that drive craving in early withdrawal. RECO Island runs a small-census, physician-led medical detox with direct in-house transition to residential treatment — no waitlists, no third-party handoffs, and no discharging a stabilized client to a phone number.

Substance-specific withdrawal protocols

Opioid, benzodiazepine, and stimulant withdrawal are clinically distinct syndromes that respond to different management. Running a single detox protocol across all substances is bad medicine and produces predictable failures — under-medicated opioid withdrawal that clients leave against medical advice by day two, benzodiazepine withdrawal treated with symptomatic comfort medications instead of a proper taper, stimulant withdrawal dismissed as something to sleep off. RECO Island’s admitting physician assesses each substance the client is dependent on separately and writes a protocol against each.

Opioid withdrawal is intensely uncomfortable but rarely medically dangerous. COWS-guided buprenorphine induction — waiting for a score in the 8 to 12 range to avoid precipitated withdrawal, then titrating over 24 to 48 hours to a stable dose — transforms the experience from the traditional acute withdrawal picture into something clinically manageable. For clients whose use pattern makes methadone the better fit (long-acting fentanyl analogs, prior failed buprenorphine trials, established OTP relationships), that pathway is coordinated with a community opioid treatment program.

Benzodiazepine withdrawal — like alcohol — can produce seizures and delirium and requires slow tapering, typically converting to a long half-life agent (clonazepam or diazepam equivalents) and tapering over weeks rather than days, monitored with CIWA-B. Stimulant withdrawal from cocaine or methamphetamine is primarily depression, anhedonia, hypersomnia, and craving without a specific medication protocol, but the clinical need for supportive care is real — PHQ-9 monitoring for suicidal ideation, treatment of comorbid depression, sleep support, and structured activity to counter the anhedonic collapse of the first two weeks.

Polysubstance detox and the sequencing decision

Concurrent dependence on alcohol, benzodiazepines, and opioids — increasingly the presenting pattern rather than the exception — requires deliberate sequencing rather than parallel improvisation. The general principle: manage life-threatening withdrawal syndromes first (alcohol and benzodiazepine, both of which are tracked with CIWA-Ar or CIWA-B and can produce seizures and delirium tremens), initiate opioid MAT concurrently rather than waiting, and address stimulant withdrawal supportively alongside the acute protocols.

Every polysubstance detox at RECO Island is individualized against the specific substances used, the quantities involved, the duration of use, and the last-use timeline documented from the client and, where appropriate, corroborated by family. The plan is written before the first dose, reviewed daily against CIWA and COWS scoring, and adjusted on objective response rather than clinician preference. Attempting a buprenorphine induction in the middle of an unstabilized benzodiazepine taper produces predictable problems; attempting to detox alcohol on the wrong loading protocol produces worse ones.

Medical comorbidity is the norm, not the exception

Chronic substance use produces medical comorbidity. Hepatitis C from injection use is common enough that RECO Island screens routinely rather than reactively. Cardiovascular disease from stimulant use — cardiomyopathy, arrhythmias, hypertension — shows up on admission EKG or vitals with regularity. Chronic pain that was under-treated or self-medicated into an opioid use disorder is the underlying condition rather than the addiction itself for a meaningful fraction of clients, and treating it requires a plan.

Malnutrition, undiagnosed type 2 diabetes, untreated hypertension, sleep-disordered breathing, and severe dental disease all appear predictably. For many clients, detox admission is the first sustained medical contact in years. RECO Island’s admission workup catches these conditions and initiates management concurrently — starting antihypertensives, coordinating hepatitis C treatment with community providers, treating latent TB when indicated, and adjusting psychiatric medications against the client’s actual metabolic and hepatic status — rather than handing a discharge summary to the client and telling them to find a primary care doctor.

The handoff into residential and MAT continuation

Detox produces safe withdrawal. Residential produces early-recovery skill building — CBT for relapse prevention, DBT for emotion regulation and distress tolerance, MI to work with rather than against ambivalence, ACT for values-based behavioral commitment, and EMDR for the trauma histories that drive a substantial share of substance use. MAT protects against relapse during the vulnerable weeks and months after acute withdrawal resolves and the neurobiology of craving is still normalizing.

RECO Island’s model is to initiate MAT during detox where indicated — buprenorphine for opioid use disorder, naltrexone for alcohol use disorder or for OUD after an appropriate opioid-free window — continue it through residential and PHP/IOP, and hand off to community MAT maintenance at discharge with a scheduled first appointment already on the calendar. Detox alone, without residential and without MAT, has a well-documented relapse rate that borders on universal. Discharging a stabilized opioid client to no medication and no structure isn’t discharge planning; it’s overdose risk management run in reverse.

What admission from Jupiter looks like

Admission begins with a phone assessment covering substance-use history, last-use timeline, medical and psychiatric history, and current medications. Insurance verification runs in parallel, and most families reach a bed decision the same day they call. Transport from Jupiter is 45 minutes; families in Abacoa and Tequesta routinely drive clients directly to the Delray campus with a packed bag rather than using medical transport.

On arrival: full medical intake, vitals, urine toxicology, EKG, comprehensive metabolic and hepatic panels, and a psychiatric evaluation on day one. CIWA and COWS scoring begin immediately for anyone at withdrawal risk. The physician’s detox order goes in that day, and medication is on board before withdrawal escalates rather than after. The first 48 hours run in the medical unit; step-down into the residential milieu is clinical rather than calendar-driven, and the same primary clinician follows the client from detox through residential and into aftercare planning.

Insurance and admissions from Palm Beach County

RECO Island is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans, which covers most commercially insured families in Jupiter and the surrounding Palm Beach County market. Detox is generally authorized when clinical criteria are documented against the ASAM Criteria dimensions — acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment. Verification is typically completed within the same business day a family calls, and single-case agreements are negotiated for out-of-network commercial coverage where clinically indicated.

Serving residents of: Abacoa, Jupiter Inlet Colony, Tequesta, Admirals Cove, Jonathan's Landing.